12,000 Fake Weight-Loss Pens Seized in UK: What to Know

Counterfeit weight-loss injection pens seized during a UK medicines enforcement operation

MEDISEARCHER NEWS

United Kingdom · Weight-loss medicines · 16 October 2026

In brief

UK authorities have seized more than 12,000 fake retatrutide and tirzepatide injection pens during a raid on an industrial unit in Birmingham.
The Medicines and Healthcare products Regulatory Agency (MHRA) estimates the seized products were worth approximately £2 million.
Investigators also found packaging for around 30,000 additional products, indicating a potentially much larger illegal supply operation.
The MHRA warns that the products had not been assessed for safety, quality or effectiveness and there is no guarantee of what they contain or whether they are contaminated.
Tirzepatide is an authorised prescription medicine in the UK, but counterfeit versions may be sold illegally. Retatrutide remains investigational and has not been authorised for use in the UK.
The Birmingham seizure is the latest in a series of major UK enforcement operations targeting illegal weight-loss medicines.

More than 12,000 fake weight-loss injection pens worth approximately £2 million have been seized from an industrial unit in Birmingham as UK regulators intensify action against the illegal market for high-demand obesity medicines.

The Medicines and Healthcare products Regulatory Agency (MHRA) and West Midlands Police carried out the operation on 14 October 2026, seizing products presented as retatrutide and tirzepatide.

Investigators also discovered packaging for around 30,000 additional products, suggesting that the potential scale of the operation extended considerably beyond the finished injection pens recovered during the raid.

The MHRA has warned that the seized products had not been assessed for safety, quality or effectiveness and that there is no guarantee of what they contain or whether they have been contaminated with harmful substances.

The case is particularly relevant to people searching for weight-loss medicines online because it involves two very different categories of medicine: tirzepatide is an authorised prescription treatment in the UK, while retatrutide remains investigational and has not been authorised for use in the UK.

What did UK authorities seize in Birmingham?

The joint operation by the MHRA’s Criminal Enforcement Unit and West Midlands Police took place at an industrial unit in Birmingham on 14 October.

According to the MHRA, investigators seized:

more than 12,000 fake retatrutide and tirzepatide pens;
products with an estimated value of approximately £2 million; and
packaging intended for around 30,000 additional products.

The MHRA described the location as a filthy warehouse and warned that the products had not undergone the regulatory assessment and manufacturing controls required for authorised medicines.

That creates risks beyond simply receiving a medicine that does not work. With an illegally manufactured injectable product, there may be no reliable way for the buyer to know what substance is actually inside the pen, what dose it contains, whether it was manufactured under sterile conditions or whether it has been contaminated.

Were the seized weight-loss pens genuine Mounjaro?

No. The MHRA described the seized tirzepatide and retatrutide products as fake.

Tirzepatide is the active ingredient in Mounjaro, an authorised prescription medicine used in the UK for specified indications including type 2 diabetes and weight management.

The existence of genuine authorised tirzepatide does not mean that every injection pen or vial advertised online as tirzepatide is authentic.

Counterfeiters can imitate medicine packaging, injection devices and branding or sell products described by an active ingredient rather than a recognised brand.

A professional-looking website, box or injection pen therefore does not establish that a medicine has come through a legitimate pharmaceutical supply chain.

Is retatrutide approved in the UK?

No.

Retatrutide is an investigational medicine being studied as a potential treatment for obesity and related metabolic conditions, but it has not been authorised for routine use in the United Kingdom.

The MHRA states that products being sold as retatrutide outside legitimate clinical trials are being supplied illegally and could pose serious risks to public health.

This distinction is important because retatrutide has attracted considerable attention online as clinical research into the medicine has progressed.

Public awareness of an experimental medicine can develop long before regulators have approved it. Illegal sellers can exploit that gap by advertising supposed versions of a drug that patients cannot yet legitimately obtain from ordinary pharmacies.

A medicine being evaluated in clinical trials is not the same as an approved medicine available for routine prescribing.

Is tirzepatide legal in the UK?

Yes, but legitimate tirzepatide is a prescription-only medicine.

Tirzepatide is authorised in the UK and can be prescribed to appropriate patients following clinical assessment.

The problem highlighted by the Birmingham raid is not that tirzepatide itself is illegal. It is that criminals can manufacture or distribute products falsely presented as tirzepatide outside the regulated medicines supply chain.

Patients considering GLP-1 or related weight-loss treatment should therefore distinguish between an authorised medicine prescribed and supplied through legitimate healthcare channels and a product merely claiming to contain the same active ingredient.

Why can fake weight-loss injections be dangerous?

Counterfeit and illegally manufactured injectable medicines can create several different risks.

The MHRA says the products seized in Birmingham had not been assessed for safety, quality or effectiveness and that there was no guarantee of what they contained or whether they had been contaminated with harmful substances.

Potential problems with illegally supplied medicines can include:

the wrong active ingredient;
too much or too little of the claimed active ingredient;
undeclared pharmaceutical substances;
harmful contaminants;
poor or non-sterile manufacturing conditions;
incorrect storage or transport;
fake or misleading packaging; and
use without appropriate clinical assessment or follow-up.

Manufacturing quality is particularly important for injectable medicines because the product bypasses many of the body’s normal barriers when it is injected through the skin.

Visual inspection alone cannot reliably establish whether an injection pen contains the medicine stated on its packaging.

How big is the illegal weight-loss medicine problem in the UK?

The Birmingham raid is the latest in a series of substantial enforcement operations involving unauthorised or counterfeit weight-loss medicines.

In May 2026, the MHRA arrested two people after raiding a country estate near Northampton that investigators believed was being used to manufacture, assemble and distribute unlicensed weight-loss medicines.

Approximately 12,000 doses were recovered during that operation together with packaging materials and suspected pharmaceutical substances.

In February 2026, around 2,000 doses of unauthorised weight-loss medicines awaiting dispatch were seized alongside manufacturing equipment, suspected pharmaceutical ingredients, packaging and commercial vehicles.

The MHRA had already discovered a major illicit weight-loss medicine production facility in Northampton in October 2025, where officers seized thousands of unauthorised retatrutide and tirzepatide pens, empty injection pens and raw chemical ingredients.

The repeated discoveries indicate that the illegal market is not limited to isolated individuals reselling a few medicines online. UK authorities are confronting organised operations capable of manufacturing, assembling, packaging and distributing weight-loss products on a substantial scale.

Why are counterfeit weight-loss medicines becoming a problem?

Modern obesity medicines have generated exceptionally strong consumer demand.

Medicines acting on GLP-1 and related metabolic pathways have changed the treatment of obesity and type 2 diabetes, while new medicines still undergoing clinical development have attracted significant public and media attention.

That demand creates opportunities for illegal sellers.

People who cannot obtain treatment through ordinary healthcare channels, face shortages, want lower prices or hope to access an experimental medicine before approval may be particularly vulnerable to unregulated sellers.

Retatrutide illustrates the problem clearly. Interest in the medicine exists before regulatory approval, meaning online searches for the drug can lead consumers towards sellers offering products that are not part of any authorised pharmacy supply chain.

How can you check whether an online weight-loss medicine provider is legitimate?

Prescription weight-loss medicines should not be treated like ordinary online retail products.

The MHRA advises anyone considering GLP-1 treatment to speak with a healthcare professional and obtain medicines only from a registered pharmacy against a valid prescription.

Consumers should also check whether a UK online pharmacy is properly registered before ordering prescription medicines online. MediSearcher’s guide to warning signs of a fake or unsafe online pharmacy explains additional red flags to look for when assessing a medicine seller.

Consumers in the UK can reduce the risk of encountering counterfeit or illegal products by taking several precautions:

Check the pharmacy’s registration. In Great Britain, pharmacies can be checked through the General Pharmaceutical Council register. Northern Ireland has a separate pharmacy regulator.
Expect a genuine clinical assessment. Prescription-only weight-loss medicines should not simply be sold without an assessment of whether treatment is appropriate.
Be highly suspicious of anyone offering retatrutide for routine purchase. Retatrutide is not currently authorised for use in the UK.
Avoid informal sellers. Social-media accounts, messaging apps and other unregulated sellers do not provide the safeguards associated with a registered pharmacy.
Do not assume professional packaging proves authenticity. Counterfeiters can imitate boxes, labels and injection devices.
Be cautious about unusually low prices or claims of unrestricted access. Genuine prescription medicines remain subject to prescribing and pharmacy requirements.

The regulatory status of the seller and the medicine is more important than how convincing the website or packaging appears.

What is the difference between counterfeit tirzepatide and illegal retatrutide?

The distinction is important.

Tirzepatide is an authorised prescription medicine in the UK. Genuine tirzepatide can therefore legally be prescribed and supplied through regulated healthcare and pharmacy channels. A fake product falsely presented as tirzepatide is a counterfeit or otherwise illegally supplied version of an authorised medicine.

Retatrutide has not been authorised for routine use in the UK. Products being offered directly to consumers as retatrutide outside legitimate clinical trials are therefore not authorised UK pharmacy products.

Neither situation should be confused with participation in a legitimate clinical trial, where investigational medicines are supplied under controlled research protocols with defined eligibility criteria, monitoring and oversight.

What should you do if you think you bought a fake weight-loss pen?

If you suspect that a weight-loss injection may be counterfeit or was obtained from an unregulated source, do not assume that its contents match the label.

Anyone who has already used the product should contact a pharmacist, doctor or other appropriately qualified healthcare professional for advice, particularly if they develop unexpected symptoms or side effects.

Suspected adverse reactions and medicine safety problems can be reported through the MHRA Yellow Card scheme.

Information about suspicious or illegally supplied medicines can also help regulators identify unsafe products and illegal sellers.

Anyone experiencing severe or rapidly worsening symptoms after using an unknown or potentially counterfeit injectable medicine should seek urgent medical attention.

What does the Birmingham seizure mean for patients?

The seizure provides another warning that growing demand for weight-loss treatment has created a substantial illegal market alongside legitimate prescribing and pharmacy services.

For patients, one of the most important lessons is that the name printed on an injection pen does not establish what is actually inside it.

This is particularly important when searching online for medicines such as tirzepatide or experimental treatments such as retatrutide.

Authorised prescription medicines should be obtained through regulated healthcare and pharmacy channels, while investigational medicines that have not received marketing authorisation should not be treated as ordinary products available for online purchase.

The Birmingham investigation may also lead to further enforcement action as authorities examine the scale and distribution network associated with the seized products.

MediSearcher will update this article if the MHRA, police or other authorities announce significant new findings, arrests, charges, laboratory results or further safety information connected with the operation.

Reviewed by: Dr Mattias Hagman, PhD

Editorial review: This article was reviewed for source accuracy, medicine-regulation context and consistency with MediSearcher’s editorial standards. Information about the Birmingham seizure, the regulatory status of retatrutide, the risks associated with counterfeit weight-loss medicines and previous UK enforcement operations was checked against Medicines and Healthcare products Regulatory Agency information and official UK medicines-safety guidance.

Last reviewed: 16 October 2026

Sources and verification

MediSearcher reviewed the following primary and authoritative sources when preparing this article:

MediSearcher provides general information about medicines, medicine safety and healthcare. Retatrutide is not currently authorised for use in the UK, while tirzepatide is a prescription-only medicine that should be obtained through legitimate regulated healthcare and pharmacy channels. This article does not provide personal medical advice. Anyone concerned that they have used a counterfeit or illegally supplied medicine should seek advice from an appropriately qualified healthcare professional.